Intestinal microbiota and overweight
In: Beneficial MicrobesSearch for other papers by A. Lyra in
Current site
Google Scholar
Search for other papers by S. Lahtinen in
Current site
Google Scholar
Search for other papers by K. Tiihonen in
Current site
Google Scholar
Search for other papers by A. Ouwehand in
Current site
Google Scholar
The microbes in our gut can influence our weight by providing us with energy through the degradation of nondigestable carbohydrates and by affecting the cellular energy status of liver and muscle cells and the accumulation of lipids in adipose tissue. Thus, it is not surprising that in several studies the gastrointestinal microbiota of overweight and obese subjects has been found to differ from that of lean subjects. The initial findings linked obesity with proportionally decreased levels of the phylum Bacteroidetes and increased levels of the phylum Firmicutes. Later, several studies have assessed the association between overweight or obesity and the gastrointestinal microbiota, applying an array of molecular methods _targeting the microbiota as a whole or specific bacterial groups or species within. However, at present it is difficult to draw conclusions on which of the observed microbiota alterations are relevant; essentially all of the bacterial groups that have been studied in more than one trial have given contradictory results in regard to their association with weight. Some of these discrepancies can result from methodological issues and some from the nature of the gastrointestinal microbiota, which is an extremely complex and dynamic microbial ecosystem with high subject specificity. In addition, selecting subjects purely based on weight may result in a largely heterogeneous group with several potentially confounding factors. While it may be premature to conclude which specific groups of bacteria are prominent in the intestinal tract of overweight and obese subjects, it appears clear that microbes contribute to weight gain and related health issues, such as the metabolic syndrome and type II diabetes. Therefore, it is important to continue to search for common microbial markers and predictors of obesity, and to study how these may be modulated with probiotics and prebiotics to promote health.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
-
Al-Attas, O.S., Al-Daghri, N.M., Al-Rubeaan, K., Da Silva, N.F., Sabico, S.L., Kumar, S., McTernan, P.G. and Harte, A.L., 2009. Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies. Cardiovascular Diabetology 8: 20.
'Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies ' () 8 Cardiovascular Diabetology : 20.
-
Alberti, K.G., Eckel, R.H., Grundy, S.M., Zimmet, P.Z., Cleeman, J.I., Donato, K.A., Fruchart, J.C., James, W.P., Loria, C.M. and Smith, S.C., Jr., 2009. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645.
'Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity ' () 120 Circulation : 1640 -1645.
-
Al-Salami, H., Butt, G., Fawcett, J.P., Tucker, I.G., Golocorbin-Kon, S. and Mikov, M., 2008. Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats. European Journal of Drug Metabolism and Pharmacokinetics 33: 101-106.
'Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats ' () 33 European Journal of Drug Metabolism and Pharmacokinetics : 101 -106.
-
Amar, J., Burcelin, R., Ruidavets, J.B., Cani, P.D., Fauvel, J., Alessi, M.C., Chamontin, B. and Ferrieres, J., 2008. Energy intake is associated with endotoxemia in apparently healthy men. American Journal of Clinical Nutrition 87: 1219-1223.
'Energy intake is associated with endotoxemia in apparently healthy men ' () 87 American Journal of Clinical Nutrition : 1219 -1223.
-
Armougom, F. and Raoult, D., 2008. Use of pyrosequencing and DNA barcodes to monitor variations in Firmicutes and Bacteroidetes communities in the gut microbiota of obese humans. BMC Genomics 9: 576.
'Use of pyrosequencing and DNA barcodes to monitor variations in Firmicutes and Bacteroidetes communities in the gut microbiota of obese humans ' () 9 BMC Genomics : 576.
-
Armougom, F., Henry, M., Vialettes, B., Raccah, D. and Raoult, D., 2009. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and methanogens in anorexic patients. PLoS ONE 4: e7125.
-
Bäckhed, F. and Crawford, P.A., 2010. Coordinated regulation of the metabolome and lipidome at the host-microbial interface. Biochimica et Biophysica Acta 1801: 240-245.
'Coordinated regulation of the metabolome and lipidome at the host-microbial interface ' () 1801 Biochimica et Biophysica Acta : 240 -245.
-
Bäckhed, F., Ding, H., Wang, T., Hooper, L.V., Koh, G.Y., Nagy, A., Semenkovich, C.F. and Gordon, J.I., 2004. The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the USA 101: 15718-15723.
'The gut microbiota as an environmental factor that regulates fat storage ' () 101 Proceedings of the National Academy of Sciences of the USA : 15718 -15723.
-
Batterham, R.L., Cohen, M.A., Ellis, S.M., Le Roux, C.W., Withers, D.J., Frost, G.S., Ghatei, M.A. and Bloom, S.R., 2003. Inhibition of food intake in obese subjects by peptide YY3-36. The New England Journal of Medicine 349: 941-948.
'Inhibition of food intake in obese subjects by peptide YY3-36 ' () 349 The New England Journal of Medicine : 941 -948.
-
Bays, H.E., 2009. 'Sick fat', metabolic disease, and atherosclerosis. American Journal of Medicine 122: S26-S37.
''Sick fat', metabolic disease, and atherosclerosis ' () 122 American Journal of Medicine : S26 -S37.
-
Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A.M., Fava, F., Tuohy, K.M., Chabo, C., Waget, A., Delmee, E., Cousin, B., Sulpice, T., Chamontin, B., Ferrieres, J., Tanti, J.F., Gibson, G.R., Casteilla, L., Delzenne, N.M., Alessi, M.C. and Burcelin, R., 2007a. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772.
'Metabolic endotoxemia initiates obesity and insulin resistance ' () 56 Diabetes : 1761 -1772.
-
Cani, P.D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A.M., Delzenne, N.M. and Burcelin, R., 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57: 1470-1481.
'Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice ' () 57 Diabetes : 1470 -1481.
-
Cani, P.D., Knauf, C., Iglesias, M.A., Drucker, D.J., Delzenne, N.M. and Burcelin, R., 2006. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 55: 1484-1490.
'Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor ' () 55 Diabetes : 1484 -1490.
-
Cani, P.D., Neyrinck, A.M., Fava, F., Knauf, C., Burcelin, R.G., Tuohy, K.M., Gibson, G.R. and Delzenne, N.M., 2007b. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50: 2374-2383.
'Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia ' () 50 Diabetologia : 2374 -2383.
-
Cani, P.D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D.M., Muccioli, G.G. and Delzenne, N.M., 2009. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58: 1091-1103.
'Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability ' () 58 Gut : 1091 -1103.
-
Castell, J.V., Gomez-Lechon, M.J., David, M., Hirano, T., Kishimoto, T. and Heinrich, P.C., 1988. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Letters 232: 347-350.
'Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes ' () 232 FEBS Letters : 347 -350.
-
Collado, M.C., Isolauri, E., Laitinen, K. and Salminen, S., 2008. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. American Journal of Clinical Nutrition 88: 894-899.
'Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women ' () 88 American Journal of Clinical Nutrition : 894 -899.
-
Considine, R.V., Sinha, M.K., Heiman, M.L., Kriauciunas, A., Stephens, T.W., Nyce, M.R., Ohannesian, J.P., Marco, C.C., McKee, L.J., Bauer, T.L. and Caro, J.F., 1996. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. The New England Journal of Medicine 334: 292-295.
'Serum immunoreactive-leptin concentrations in normal-weight and obese humans ' () 334 The New England Journal of Medicine : 292 -295.
-
Couillard, C., Bergeron, N., Prud'homme, D., Bergeron, J., Tremblay, A., Bouchard, C., Mauriege, P. and Despres, J.P., 1998. Postprandial triglyceride response in visceral obesity in men. Diabetes 47: 953-960.
'Postprandial triglyceride response in visceral obesity in men ' () 47 Diabetes : 953 -960.
-
Creely, S.J., McTernan, P.G., Kusminski, C.M., Fisher, M., Da Silva, N.F., Khanolkar, M., Evans, M., Harte, A.L. and Kumar, S., 2007. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. American Journal of Physiology -Endocrinology and Metabolism 292: E740-E747.
'Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes ' () 292 American Journal of Physiology -Endocrinology and Metabolism : E740 -E747.
-
Derrien, M., Collado, M.C., Ben-Amor, K., Salminen, S. and De Vos, W.M., 2008. The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Applied and Environmental Microbiology 74: 1646-1648.
'The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract ' () 74 Applied and Environmental Microbiology : 1646 -1648.
-
Duncan, S.H., Lobley, G.E., Holtrop, G., Ince, J., Johnstone, A.M., Louis, P. and Flint, H.J., 2008. Human colonic microbiota associated with diet, obesity and weight loss. International Journal of Obesity 32: 1720-1724.
'Human colonic microbiota associated with diet, obesity and weight loss ' () 32 International Journal of Obesity : 1720 -1724.
-
Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S.R., Nelson, K.E. and Relman, D.A., 2005. Diversity of the human intestinal microbial flora. Science 308: 1635-1638.
'Diversity of the human intestinal microbial flora ' () 308 Science : 1635 -1638.
-
Ekhart, P.F., Van Geel-Schutten, G.H., Van Binsbere, M.M. and Timmerman, E.J., 2004. Branched a-glucans for weight management. Patent WO 2004/022076 A1 (the Netherlands).
-
Fawcett, K.A. and Barroso, I., 2010. The genetics of obesity: FTO leads the way. Trends in Genetics 26: 266-274.
'The genetics of obesity: FTO leads the way ' () 26 Trends in Genetics : 266 -274.
-
Fleissner, C.K., Huebel, N., Abd El-Bary, M.M., Loh, G., Klaus, S. and Blaut, M., 2010. Absence of intestinal microbiota does not protect mice from diet-induced obesity. The British Journal of Nutrition 104: 919-929.
'Absence of intestinal microbiota does not protect mice from diet-induced obesity ' () 104 The British Journal of Nutrition : 919 -929.
-
Fried, S.K., Bunkin, D.A. and Greenberg, A.S., 1998. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. Journal of Clinical Endocrinology and Metabolism 83: 847-850.
'Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid ' () 83 Journal of Clinical Endocrinology and Metabolism : 847 -850.
-
Gregor, M.G. and Hotamisligil, G.S., 2007. Adipocyte stress: the endoplasmic reticulum and metabolic disease. Journal of Lipid Research 48: 1905-1914.
'Adipocyte stress: the endoplasmic reticulum and metabolic disease ' () 48 Journal of Lipid Research : 1905 -1914.
-
Hamad, E.M., Sato, M., Uzu, K., Yoshida, T., Higashi, S., Kawakami, H., Kadooka, Y., Matsuyama, H., Abd El-Gawad, I.A. and Imaizumi, K., 2009. Milk fermented by Lactobacillus gasseri SBT2055 influences adipocyte size via inhibition of dietary fat absorption in Zucker rats. The British Journal of Nutrition 101: 716-724.
'Milk fermented by Lactobacillus gasseri SBT2055 influences adipocyte size via inhibition of dietary fat absorption in Zucker rats ' () 101 The British Journal of Nutrition : 716 -724.
-
Hildebrandt, M.A., Hoffmann, C., Sherrill-Mix, S.A., Keilbaugh, S.A., Hamady, M., Chen, Y.Y., Knight, R., Ahima, R.S., Bushman, F. and Wu, G.D., 2009. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137: 1716-1724.
'High-fat diet determines the composition of the murine gut microbiome independently of obesity ' () 137 Gastroenterology : 1716 -1724.
-
Hill, J.E., Fernando, W.M., Zello, G.A., Tyler, R.T., Dahl, W.J. and Van Kessel, A.G., 2010. Improvement of the representation of bifidobacteria in fecal microbiota metagenomic libraries by application of the cpn60 universal primer cocktail. Applied and Environmental Microbiology 76: 4550-4552.
'Improvement of the representation of bifidobacteria in fecal microbiota metagenomic libraries by application of the cpn60 universal primer cocktail ' () 76 Applied and Environmental Microbiology : 4550 -4552.
-
Hotamisligil, G.S., Shargill, N.S. and Spiegelman, B.M., 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91.
'Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance ' () 259 Science : 87 -91.
-
Hoyles, L. and McCartney, A.L., 2009. What do we mean when we refer to Bacteroidetes populations in the human gastrointestinal microbiota? FEMS Microbiology Letters 299: 175-183.
'What do we mean when we refer to Bacteroidetes populations in the human gastrointestinal microbiota ' () 299 FEMS Microbiology Letters : 175 -183.
-
Isolauri, E., Kalliomäki, M., Rautava, S., Salminen, S. and Laitinen, K., 2009. Obesity -extending the hygiene hypothesis. Nestlé Nutrition Institute Workshop Series: Paediatric Program 64: 75-85.
'Obesity -extending the hygiene hypothesis ' () 64 Nestlé Nutrition Institute Workshop Series: Paediatric Program : 75 -85.
-
Kadooka, Y., Sato, M., Imaizumi, K., Ogawa, A., Ikuyama, K., Akai, Y., Okano, M., Kagoshima, M. and Tsuchida, T., 2010. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. European Journal of Clinical Nutrition 64: 636-643.
'Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial ' () 64 European Journal of Clinical Nutrition : 636 -643.
-
Kalliomäki, M., Collado, M.C., Salminen, S. and Isolauri, E., 2008. Early differences in fecal microbiota composition in children may predict overweight. The American Journal of Clinical Nutrition 87: 534-538.
'Early differences in fecal microbiota composition in children may predict overweight ' () 87 The American Journal of Clinical Nutrition : 534 -538.
-
Kalliomäki, M., Kirjavainen, P., Eerola, E., Kero, P., Salminen, S. and Isolauri, E., 2001. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. Journal of Allergy and Clinical Immunology 107: 129-134.
'Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing ' () 107 Journal of Allergy and Clinical Immunology : 129 -134.
-
Knight, Z.A., Hannan, K.S., Greenberg, M.L. and Friedman, J.M., 2010. Hyperleptinemia is required for the development of leptin resistance. PLoS ONE 5: e11376.
-
Kondo, S., Xiao, J. Z., Satoh, T., Odamaki, T., Takahashi, S., Sugahara, H., Yaeshima, T., Iwatsuki, K., Kamei, A. and Abe, K., 2010. Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity. Bioscience, Biotechnology and Biochemistry 74: 1656-1661.
'Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity ' () 74 Bioscience, Biotechnology and Biochemistry : 1656 -1661.
-
Kopelman, P., 2007. Health risks associated with overweight and obesity. Obesity Reviews 8 Suppl.: 13-17.
-
Krogius-Kurikka, L., Kassinen, A., Paulin, L., Corander, J., Makivuokko, H., Tuimala, J. and Palva, A., 2009. Sequence analysis of percent G+C fraction libraries of human faecal bacterial DNA reveals a high number of Actinobacteria. BMC Microbiology 9: 68.
'Sequence analysis of percent G+C fraction libraries of human faecal bacterial DNA reveals a high number of Actinobacteria ' () 9 BMC Microbiology : 68.
-
Kunin, V., Engelbrektson, A., Ochman, H. and Hugenholtz, P., 2010. Wrinkles in the rare biosphere: pyrosequencing errors can lead to artificial inflation of diversity estimates. Environmental Microbiology 12: 118-123.
'Wrinkles in the rare biosphere: pyrosequencing errors can lead to artificial inflation of diversity estimates ' () 12 Environmental Microbiology : 118 -123.
-
Larsen, N., Vogensen, F.K., Van den Berg, F.W., Nielsen, D.S., Andreasen, A.S., Pedersen, B.K., Al-Soud, W.A., Sorensen, S.J., Hansen, L.H. and Jakobsen, M., 2010. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 5: e9085.
-
Lee, H.Y., Park, J.H., Seok, S.H., Baek, M.W., Kim, D.J., Lee, K.E., Paek, K.S., Lee, Y. and Park, J.H., 2006. Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice. Biochimica et Biophysica Acta 1761: 736-744.
'Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice ' () 1761 Biochimica et Biophysica Acta : 736 -744.
-
Ley, R.E., 2010. Obesity and the human microbiome. Current Opinion in Gastroenterology 26: 5-11.
'Obesity and the human microbiome ' () 26 Current Opinion in Gastroenterology : 5 -11.
-
Ley, R.E., Bäckhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D. and Gordon, J.I., 2005. Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of the USA 102: 11070-11075.
'Obesity alters gut microbial ecology ' () 102 Proceedings of the National Academy of Sciences of the USA : 11070 -11075.
-
Ley, R.E., Turnbaugh, P.J., Klein, S. and Gordon, J.I., 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022-1023.
'Microbial ecology: human gut microbes associated with obesity ' () 444 Nature : 1022 -1023.
-
Li, P. and Hotamisligil, G.S., 2010. Metabolism: host and microbes in a pickle. Nature 464: 1287-1288.
'Metabolism: host and microbes in a pickle ' () 464 Nature : 1287 -1288.
-
Louis, P., Young, P., Holtrop, G. and Flint, H.J., 2010. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environmental Microbiology 12: 304-314.
'Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene ' () 12 Environmental Microbiology : 304 -314.
-
Luoto, R., Kalliomäki, M., Laitinen, K. and Isolauri, E., 2010. The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. International Journal of Obesity 34: 1531-1537.
'The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years ' () 34 International Journal of Obesity : 1531 -1537.
-
Malinen, E., Krogius-Kurikka, L., Lyra, A., Nikkilä, J., Jääseläinen, A., Rinttilä, T., Vilpponen-Salmela, T., Von Wright, A. and Palva, A., 2010. Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome. World Journal of Gastroenterology 16: 4532-4540.
'Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome ' () 16 World Journal of Gastroenterology : 4532 -4540.
-
Malinen, E., Rinttilä, T., Kajander, K., Mättö, J., Kassinen, A., Krogius, L., Saarela, M., Korpela, R. and Palva, A., 2005. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. The American Journal of Gastroenterology 100: 373-382.
'Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR ' () 100 The American Journal of Gastroenterology : 373 -382.
-
Maslowski, K.M., Vieira, A.T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H.C., Rolph, M.S., Mackay, F., Artis, D., Xavier, R.J., Teixeira, M.M. and Mackay, C.R., 2009. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461: 1282-1286.
'Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 ' () 461 Nature : 1282 -1286.
-
Membrez, M., Blancher, F., Jaquet, M., Bibiloni, R., Cani, P.D., Burcelin, R.G., Corthesy, I., Mace, K. and Chou, C.J., 2008. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB Journal 22: 2416-2426.
'Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice ' () 22 FASEB Journal : 2416 -2426.
-
Must, A., Spadano, J., Coakley, E.H., Field, A.E., Colditz, G. and Dietz, W.H., 1999. The disease burden associated with overweight and obesity. JAMA 282: 1523-1529.
'The disease burden associated with overweight and obesity ' () 282 JAMA : 1523 -1529.
-
Nadal, I., Santacruz, A., Marcos, A., Warnberg, J., Garagorri, M., Moreno, L.A., Martin-Matillas, M., Campoy, C., Marti, A., Moleres, A., Delgado, M., Veiga, O.L., Garcia-Fuentes, M., Redondo, C.G. and Sanz, Y., 2009. Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents. International Journal of Obesity 33: 758-767.
'Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents ' () 33 International Journal of Obesity : 758 -767.
-
Nelson, K.E., Weinstock, G.M., Highlander, S.K., Worley, K.C., Creasy, H.H., Wortman, J.R., Rusch, D.B., Mitreva, M., Sodergren, E., Chinwalla, A.T., Feldgarden, M., Gevers, D., Haas, B.J., Madupu, R., Ward, D.V., Birren, B.W., Gibbs, R.A., Methe, B., Petrosino, J.F., Strausberg, R.L., Sutton, G.G., White, O.R., Wilson, R.K., Durkin, S., Giglio, M.G., Gujja, S., Howarth, C., Kodira, C.D., Kyrpides, N., Mehta, T., Muzny, D.M., Pearson, M., Pepin, K., Pati, A., Qin, X., Yandava, C., Zeng, Q., Zhang, L., Berlin, A.M., Chen, L., Hepburn, T.A., Johnson, J., McCorrison, J., Miller, J., Minx, P., Nusbaum, C., Russ, C., Sykes, S.M., Tomlinson, C.M., Young, S., Warren, W.C., Badger, J., Crabtree, J., Markowitz, V.M., Orvis, J., Cree, A., Ferriera, S., Fulton, L.L., Fulton, R.S., Gillis, M., Hemphill, L.D., Joshi, V., Kovar, C., Torralba, M., Wetterstrand, K.A., Abouellleil, A., Wollam, A.M., Buhay, C.J., Ding, Y., Dugan, S., FitzGerald, M.G., Holder, M., Hostetler, J., Clifton, S.W., Allen-Vercoe, E., Earl, A.M., Farmer, C.N., Liolios, K., Surette, M.G., Xu, Q., Pohl, C., Wilczek-Boney, K. and Zhu, D., 2010. A catalog of reference genomes from the human microbiome. Science 328: 994-999.
'A catalog of reference genomes from the human microbiome ' () 328 Science : 994 -999.
-
Nerstedt, A., Nilsson, E.C., Ohlson, K., Hakansson, J., Thomas Svensson, L., Lowenadler, B., Svensson, U.K. and Mahlapuu, M., 2007. Administration of Lactobacillus evokes coordinated changes in the intestinal expression profile of genes regulating energy homeostasis and immune phenotype in mice. British Journal of Nutrition 97: 1117-1127.
'Administration of Lactobacillus evokes coordinated changes in the intestinal expression profile of genes regulating energy homeostasis and immune phenotype in mice ' () 97 British Journal of Nutrition : 1117 -1127.
-
Ohlson, K., Mahlapuu, M. and Svensson, U., 2007. Products to influence fat metabolism and obesity. Patent WO 2007/043933 (Sweden).
-
Png, C.W., Linden, S.K., Gilshenan, K.S., Zoetendal, E.G., McSweeney, C.S., Sly, L.I., McGuckin, M.A. and Florin, T.H., 2010. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. The American Journal of Gastroenterology, in press. DOI:10.1038/ajg.2010.281.
-
Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K.S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., Yamada, T., Mende, D.R., Li, J., Xu, J., Li, S., Li, D., Cao, J., Wang, B., Liang, H., Zheng, H., Xie, Y., Tap, J., Lepage, P., Bertalan, M., Batto, J.M., Hansen, T., Le, Paslier D., Linneberg, A., Nielsen, H.B., Pelletier, E., Renault, P., Sicheritz-Ponten, T., Turner, K., Zhu, H., Yu, C., Li, S., Jian, M., Zhou, Y., Li, Y., Zhang, X., Li, S., Qin, N., Yang, H., Wang, J., Brunak, S., Dore, J., Guarner, F., Kristiansen, K., Pedersen, O., Parkhill, J., Weissenbach, J., Antolin, M., Artiguenave, F., Blottiere, H., Borruel, N., Bruls, T., Casellas, F., Chervaux, C., Cultrone, A., Delorme, C., Denariaz, G., Dervyn, R., Forte, M., Friss, C., Van de Guchte, M., Guedon, E., Haimet, F., Jamet, A., Juste, C., Kaci, G., Kleerebezem, M., Knol, J., Kristensen, M., Layec, S., Le Roux, K., Leclerc, M., Maguin, E., Minardi, R.M., Oozeer, R., Rescigno, M., Sanchez, N., Tims, S., Torrejon, T., Varela, E., De Vos, W., Winogradsky, Y., Zoetendal, E., Bork, P., Ehrlich, S.D. and Wang, J., 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59-65.
'A human gut microbial gene catalogue established by metagenomic sequencing ' () 464 Nature : 59 -65.
-
Rajilić-Stojanović, M., Heilig, H.G., Molenaar, D., Kajander, K., Surakka, A., Smidt, H. and De Vos, W.M., 2009. Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environmental Microbiology 11: 1736-1751.
'Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults ' () 11 Environmental Microbiology : 1736 -1751.
-
Randle, P.J., 1963. Control of insulin secretion in health and disease. Israel Medical Journal 22: 408-419.
'Control of insulin secretion in health and disease ' () 22 Israel Medical Journal : 408 -419.
-
Ranganath, L.R., Beety, J.M., Morgan, L.M., Wright, J.W., Howland, R. and Marks, V., 1996. Attenuated GLP-1 secretion in obesity: cause or consequence? Gut 38: 916-919.
'Attenuated GLP-1 secretion in obesity: cause or consequence ' () 38 Gut : 916 -919.
-
Raoult, D., 2009. Probiotics and obesity: a link? Nature Reviews Microbiology 7: 616.
'Probiotics and obesity: a link? ' () 7 Nature Reviews Microbiology : 616.
-
Redinger, R.N., 2009. Fat storage and the biology of energy expenditure. Translational Research 154: 52-60.
'Fat storage and the biology of energy expenditure ' () 154 Translational Research : 52 -60.
-
Samuel, V.T., Petersen, K.F. and Shulman, G.I., 2010. Lipid-induced insulin resistance: unravelling the mechanism. The Lancet 375: 2267-2277.
'Lipid-induced insulin resistance: unravelling the mechanism ' () 375 The Lancet : 2267 -2277.
-
Santacruz, A., Collado, M.C., Garcia-Valdes, L., Segura, M.T., Martin-Lagos, J.A., Anjos, T., Marti-Romero, M., Lopez, R.M., Florido, J., Campoy, C. and Sanz, Y., 2010. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. The British Journal of Nutrition 104: 83-92.
'Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women ' () 104 The British Journal of Nutrition : 83 -92.
-
Santacruz, A., Marcos, A., Warnberg, J., Marti, A., Martin-Matillas, M., Campoy, C., Moreno, L.A., Veiga, O., Redondo-Figuero, C., Garagorri, J.M., Azcona, C., Delgado, M., Garcia-Fuentes, M., Collado, M.C. and Sanz, Y., 2009. Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity 17: 1906-1915.
'Interplay between weight loss and gut microbiota composition in overweight adolescents ' () 17 Obesity : 1906 -1915.
-
Sanz, Y., Santacruz, A. and Gauffin, P., 2010. Gut microbiota in obesity and metabolic disorders. Proceedings of the Nutrition Society 69: 434-441.
'Gut microbiota in obesity and metabolic disorders ' () 69 Proceedings of the Nutrition Society : 434 -441.
-
Schwiertz, A., Taras, D., Schafer, K., Beijer, S., Bos, N.A., Donus, C. and Hardt, P.D., 2010. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18: 190-195.
'Microbiota and SCFA in lean and overweight healthy subjects ' () 18 Obesity : 190 -195.
-
Serino, M., Luche, E., Chabo, C., Amar, J. and Burcelin, R., 2009. Intestinal microflora and metabolic diseases. Diabetes and Metabolism 35: 262-272.
'Intestinal microflora and metabolic diseases ' () 35 Diabetes and Metabolism : 262 -272.
-
Shoelson, S.E., Herrero, L. and Naaz, A., 2007. Obesity, inflammation, and insulin resistance. Gastroenterology 132: 2169-2180.
'Obesity, inflammation, and insulin resistance ' () 132 Gastroenterology : 2169 -2180.
-
Sotos, M., Nadal, I., Marti, A., Martínez, A., Martin-Matillas, M., Campoy, C., Puertollano, M.A., Wärnberg, J., Marcos, A. and Sanz, Y., 2008. Gut microbes and obesity in adolescents. Proceedings of the Nutrition Society 67: E20.
'Gut microbes and obesity in adolescents ' () 67 Proceedings of the Nutrition Society : E20.
-
Tana, C., Umesaki, Y., Imaoka, A., Handa, T., Kanazawa, M. and Fukudo, S., 2010. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterology and Motility 22: 512-515.
'Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome ' () 22 Neurogastroenterology and Motility : 512 -515.
-
Tennyson, C.A. and Friedman, G., 2008. Microecology, obesity, and probiotics. Current Opinion in Endocrinology, Diabetes and Obesity 15: 422-427.
'Microecology, obesity, and probiotics ' () 15 Current Opinion in Endocrinology, Diabetes and Obesity : 422 -427.
-
Thuny, F., Richet, H., Casalta, J.P., Angelakis, E., Habib, G. and Raoult, D., 2010. Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. PLoS ONE 5: e9074.
-
Tiihonen, K., Ouwehand, A.C. and Rautonen, N., 2010. Effect of overweight on gastrointestinal microbiology and immunology: correlation with blood biomarkers. The British Journal of Nutrition 103: 1070-1078.
'Effect of overweight on gastrointestinal microbiology and immunology: correlation with blood biomarkers ' () 103 The British Journal of Nutrition : 1070 -1078.
-
Tilg, H., 2010. Obesity, metabolic syndrome, and microbiota: multiple interactions. Journal of Clinical Gastroenterology 44 Suppl. 1: S16-S18.
-
Trayhurn, P., Wang, B. and Wood, I.S., 2008. Hypoxia and the endocrine and signalling role of white adipose tissue. Archives of Physiology and Biochemistry 114: 267-276.
'Hypoxia and the endocrine and signalling role of white adipose tissue ' () 114 Archives of Physiology and Biochemistry : 267 -276.
-
Tsuchiya, A., Almiron-Roig, E., Lluch, A., Guyonnet, D. and Drewnowski, A., 2006. Higher satiety ratings following yogurt consumption relative to fruit drink or dairy fruit drink. Journal of American Dietetic Association 106: 550-557.
'Higher satiety ratings following yogurt consumption relative to fruit drink or dairy fruit drink ' () 106 Journal of American Dietetic Association : 550 -557.
-
Turnbaugh, P.J., Hamady, M., Yatsunenko, T., Cantarel, B.L., Duncan, A., Ley, R.E., Sogin, M.L., Jones, W.J., Roe, B.A., Affourtit, J.P., Egholm, M., Henrissat, B., Heath, A.C., Knight, R. and Gordon, J.I., 2009. A core gut microbiome in obese and lean twins. Nature 457: 480-484.
'A core gut microbiome in obese and lean twins ' () 457 Nature : 480 -484.
-
Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R. and Gordon, J.I., 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.
'An obesity-associated gut microbiome with increased capacity for energy harvest ' () 444 Nature : 1027 -1031.
-
Vijay-Kumar, M., Aitken, J.D., Carvalho, F.A., Cullender, T.C., Mwangi, S., Srinivasan, S., Sitaraman, S.V., Knight, R., Ley, R.E. and Gewirtz, A.T., 2010. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328: 228-231.
'Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5 ' () 328 Science : 228 -231.
-
Virtue, S. and Vidal-Puig, A., 2010. Adipose tissue expandability, lipotoxicity and the metabolic syndrome – an allostatic perspective. Biochimica et Biophysica Acta 1801: 338-349.
'Adipose tissue expandability, lipotoxicity and the metabolic syndrome – an allostatic perspective ' () 1801 Biochimica et Biophysica Acta : 338 -349.
-
Vrieze, A., Holleman, F., Zoetendal, E.G., De Vos, W.M., Hoekstra, J.B. and Nieuwdorp, M., 2010. The environment within: how gut microbiota may influence metabolism and body composition. Diabetologia 53: 606-613.
'The environment within: how gut microbiota may influence metabolism and body composition ' () 53 Diabetologia : 606 -613.
-
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R.E. and Tataranni, P.A., 2001. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. The Journal of Clinical Endocrinology and Metabolism 86: 1930-1935.
'Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia ' () 86 The Journal of Clinical Endocrinology and Metabolism : 1930 -1935.
-
World Health Organization (WHO), 2000. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. World Health Organization Technical Report Series 894. World Health Organization, Geneva, Switzerland.
-
Wu, X., Ma, C., Han, L., Nawaz, M., Gao, F., Zhang, X., Yu, P., Zhao, C., Li, L., Zhou, A., Wang, J., Moore, J.E., Millar, B.C. and Xu, J., 2010. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Current Microbiology 61: 69-78.
'Molecular characterisation of the faecal microbiota in patients with type II diabetes ' () 61 Current Microbiology : 69 -78.
-
Zhang, H., DiBaise, J.K., Zuccolo, A., Kudrna, D., Braidotti, M., Yu, Y., Parameswaran, P., Crowell, M.D., Wing, R., Rittmann, B.E. and Krajmalnik-Brown, R., 2009. Human gut microbiota in obesity and after gastric bypass. Proceedings of the National Academy of Sciences of the USA 106: 2365-2370.
'Human gut microbiota in obesity and after gastric bypass ' () 106 Proceedings of the National Academy of Sciences of the USA : 2365 -2370.
-
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L. and Friedman, J.M., 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432.
'Positional cloning of the mouse obese gene and its human homologue ' () 372 Nature : 425 -432.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 224 | 201 | 31 |
| Full Text Views | 6 | 4 | 0 |
| PDF Views & Downloads | 8 | 6 | 0 |
Intestinal microbiota and overweight
In: Beneficial MicrobesSearch for other papers by A. Lyra in
Current site
Google Scholar
PubMed
Search for other papers by S. Lahtinen in
Current site
Google Scholar
PubMed
Search for other papers by K. Tiihonen in
Current site
Google Scholar
PubMed
Search for other papers by A. Ouwehand in
Current site
Google Scholar
PubMed
The microbes in our gut can influence our weight by providing us with energy through the degradation of nondigestable carbohydrates and by affecting the cellular energy status of liver and muscle cells and the accumulation of lipids in adipose tissue. Thus, it is not surprising that in several studies the gastrointestinal microbiota of overweight and obese subjects has been found to differ from that of lean subjects. The initial findings linked obesity with proportionally decreased levels of the phylum Bacteroidetes and increased levels of the phylum Firmicutes. Later, several studies have assessed the association between overweight or obesity and the gastrointestinal microbiota, applying an array of molecular methods _targeting the microbiota as a whole or specific bacterial groups or species within. However, at present it is difficult to draw conclusions on which of the observed microbiota alterations are relevant; essentially all of the bacterial groups that have been studied in more than one trial have given contradictory results in regard to their association with weight. Some of these discrepancies can result from methodological issues and some from the nature of the gastrointestinal microbiota, which is an extremely complex and dynamic microbial ecosystem with high subject specificity. In addition, selecting subjects purely based on weight may result in a largely heterogeneous group with several potentially confounding factors. While it may be premature to conclude which specific groups of bacteria are prominent in the intestinal tract of overweight and obese subjects, it appears clear that microbes contribute to weight gain and related health issues, such as the metabolic syndrome and type II diabetes. Therefore, it is important to continue to search for common microbial markers and predictors of obesity, and to study how these may be modulated with probiotics and prebiotics to promote health.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 224 | 201 | 31 |
| Full Text Views | 6 | 4 | 0 |
| PDF Views & Downloads | 8 | 6 | 0 |